Abstract
INTRODUCTION
The goal of this study on the blood industry is to describe and analyze the
current markets for blood products, blood tests, and blood processing
equipment as well as present important new developments affecting every aspect
of this industry. In addition, the report provides an analysis of market value
forecasted through 2012 in constant dollars and participating company
profiles. The study covers the major aspects of blood and plasma
collection/transfusion, including autologous donations, apheresis,
fractionation, blood salvage, and stem cells. The major plasma products such
as coagulation factors, human serum albumin, and immunoglobulins are analyzed
as well. The scope and character of the blood testing segment is constantly
changing so the impact of new products, technologies, and equipment are
analyzed.
The study also covers federal regulation of the blood supply, blood system
management, an analysis of the companies serving these markets, the
international developments in blood banking, and related areas as well as
research and patents that will affect the future of the blood industry.
SCOPE OF STUDY
This report contains:
- Descriptions of various types of blood and plasma collection and
transfusion technologies including autologous donations, apheresis,
fractionation, blood salvage and stem cells, and major plasma products such as
coagulation factors, human serum albumin
- The current U.S. blood industry market status, with trends and forecasts
for growth over the next 5 years
- Technological issues including the latest trends and a thorough patent
analysis
- Analysis of federal regulations concerning blood supply and management
- Discussion of the international markets for various blood and
blood-related products.
METHODOLOGY AND INFORMATION SOURCES
Data for this study were collected using both primary and secondary data
research techniques. A literature search of BCC' s extensive library as well as
scientific, medical, and business libraries was conducted. On-line databases
and government sources were consulted as well. Extensive interviews with
industry personnel, scientists, professional and trade organizations,
government agency personnel, observers, scientists, and industry professionals
were conducted.
ANALYST CREDENTIALS
Mary Anne Crandall is an expert industry analyst who has specialized in the
pharmaceutical industry for the past 15 years. She has completed several
in-depth studies on various medical topics, which has required both medical
expertise and excellent knowledge of the pharmaceutical industry. Crandall has
a master' s degree in psychology, a PhD in natural health, and is a registered
nurse (RN)/instructor at Southern Oregon University (Ashland, OR).
View Cart
